Dr Albert Minga, PhD - Université Bordeaux Segalen - Medical Doctor

Dr Albert Minga

PhD

Université Bordeaux Segalen

Medical Doctor

Abidjan, Côte d'Ivoire | Cote d'Ivoire

Main Specialties: Epidemiology

Additional Specialties: Epidemiology


Top Author

Dr Albert Minga, PhD - Université Bordeaux Segalen - Medical Doctor

Dr Albert Minga

PhD

Introduction

Docteur en Médecine
Docteur en Sciences, Technologies, Santé Option : Epidémiologie et Santé Publique
Programme PAC-CI, site ANRS, Abidjan, Côte d’Ivoire
Centre Médical de Suivi des Donneurs de Sang, Centre national de transfusion sanguine, Abidjan, Côte d’Ivoire

ADRESSE

Professionnelle Centre médical de suivi des donneurs de sang au Centre national de transfusion sanguine d’Abidjan
18 BP 1954 Abidjan 18
Téléphone 00 (225) 21 25 72 34 ou 40732382
Télécopie 00 (225) 21 25 72 34
e-mail : albert.minga@pacci.ci

Personnelle 23 BP 889 Abidjan 23
Téléphone 00 (225) 07 08 76 61
e-mail: minga.kalbert@gmail.com/minga.albert@yahoo.fr

INFORMATIONS GENERALES

Date de naissance 31 décembre 1967 à Sandougou-Soba, S/P de MAN
République de Côte d’Ivoire
Situation matrimoniale Marié, père de quatre enfants
Nationalité Ivoirienne
Langues Français (lu, parlé, écrit), anglais (lu, parlé, écrit)

DIPLOMES
1998 Doctorat d’Etat en Médecine, UFR des sciences médicales de l’Université de Cocody, Abidjan, Côte d’Ivoire
Thèse N° 2167/99

2006 MASTER, à finalité RECHERCHE, Mention SANTE PUBLIQUE, spécialité EPIDEMIOLOGIE ET BIOSTATISTIQUE, dans le domaine SCIENCES DE LA VIE ET DE LA SANTE. Institut de Santé publique, Epidémiologie et Développement. Université Victor Segalen Bordeaux 2, France N° BORDII 6145865

2011 Doctorat de L’Université BORDEAUX 2, France
Mention : Sciences, Technologies, Santé.
Option : Epidémiologie et Santé Publique
Thèse N° 1837

Primary Affiliation: Université Bordeaux Segalen - Abidjan, Côte d'Ivoire , Cote d'Ivoire

Specialties:

Additional Specialties:


View Dr Albert Minga’s Resume / CV

Education

Therapeutic management of HIV-infected patients in the national program for the care of people living with HIV since 29 March 2005.

Experience

Nov 2015
Investigator of the Phase II multicenter clinical trial, randomized, non-comparative, phase IIb, untreated trial, evaluating the safety and efficacy of three primary antiretroviral therapies, combining tenofovir-emtricitabine with zidovudine, lopinavir / Ritonavir or raltegravir in adults infected with HIV-2 in West Africa. ANRS 12294 FIT-2
Nov 2015
Investigator of the multicentre clinical trial. Feasibility, tolerance and efficacy of antiviral therapy without interferon combining sofosbuvir and ribavirin in the treatment of chronic hepatitis C genotype 1, 2 and 4 in Central and Western Africa. ANRS 12311 TAC
Nov 2015
Investigator of the Phase II multicenter clinical trial, randomized, non-comparative, phase IIb, untreated trial, evaluating the safety and efficacy of three primary antiretroviral therapies, combining tenofovir-emtricitabine with zidovudine, lopinavir / Ritonavir or raltegravir in adults infected with HIV-2 in West Africa. ANRS 12294 FIT-2
Sep 2015
Investigator of the randomized, randomized, placebo-controlled, multicenter Phase II clinical trial to evaluate the safety, tolerability and immunogenicity of three candidate vaccine regimens against Ebola In healthy adults, including elderly people, people living with HIV
Sep 2015
Investigator of the randomized, randomized, placebo-controlled, multicenter Phase II clinical trial to evaluate the safety, tolerability and immunogenicity of three candidate vaccine regimens against Ebola In healthy adults, including elderly people, people living with HIV
Sep 2015
Investigator of the randomized, randomized, placebo-controlled, multicenter Phase II clinical trial to evaluate the safety, tolerability and immunogenicity of three candidate vaccine regimens against Ebola In healthy adults, including elderly people, people living with HIV
Feb 2015
Investigator and Coordinator of the research protocol: ANRS 1220 PRIMO-CI / 12277 PRECO-CI and 12277 PRECO-CI 2. Research platform "Early detection and management of HIV infection and viral hepatitis B and C Ivory Coast "
Feb 2015
Investigator and Coordinator of the research protocol: ANRS 1220 PRIMO-CI / 12277 PRECO-CI and 12277 PRECO-CI 2. Research platform "Early detection and management of HIV infection and viral hepatitis B and C Ivory Coast "
Feb 2015
Investigator and Coordinator of the research protocol: ANRS 1220 PRIMO-CI / 12277 PRECO-CI and 12277 PRECO-CI 2. Research platform "Early detection and management of HIV infection and viral hepatitis B and C Ivory Coast "
Feb 2015
Investigator and Coordinator of the research protocol: ANRS 1220 PRIMO-CI / 12277 PRECO-CI and 12277 PRECO-CI 2. Research platform "Early detection and management of HIV infection and viral hepatitis B and C Ivory Coast "

Publications

45Publications

1135Reads

628Profile Views

920PubMed Central Citations

Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.

Authors:
Didier K Ekouevi Eric Balestre Patrick A Coffie Daouda Minta Eugene Messou Adrien Sawadogo Albert Minga Papa Salif Sow Emmanuel Bissagnene Serge P Eholie Geoffrey S Gottlieb François Dabis Djimon Marcel Zannou Carin Ahouada Jocelyn Akakpo Christelle Ahomadegbé Jules Bashi Alice Gougounon-Houéto Angèle Azon-Kouanou Fabien Houngbé Sikiratou Koumakpaï Florence Alihonou Marcelline d'Almeida Irvine Hodonou Ghislaine Hounhoui Gracien Sagbo Leïla Tossa-Bagnan Herman Adjide Joseph Drabo René Bognounou Arnaud Dienderé Eliezer Traore Lassane Zoungrana Béatrice Zerbo Adrien Bruno Sawadogo Jacques Zoungrana Arsène Héma Ibrahim Soré Guillaume Bado Achille Tapsoba Diarra Yé Fla Kouéta Sylvie Ouedraogo Rasmata Ouédraogo William Hiembo Mady Gansonré Eugène Messou Joachim Charles Gnokoro Mamadou Koné Guillaume Martial Kouakou Clarisse Amani Bosse Kouakou Brou Achi Isidore Assi Henri Chenal Denise Hawerlander Franck Soppi Albert Minga Yao Abo Germain Bomisso Serge Paul Eholié Mensah Deborah Noelly Amego Viviane Andavi Zelica Diallo Frédéric Ello Aristophane Koffi Tanon Serge Olivier Koule Koffi Charles Anzan Calixte Guehi Edmond Addi Aka Koffi Ladji Issouf Jean-Claude Kouakou Marie-Sylvie N'gbeche Pety Touré Divine Avit-Edi Kouadio Kouakou Magloire Moh Valérie Andoblé Yao Madeleine Amorissani Folquet Marie-Evelyne Dainguy Cyrille Kouakou Véronique Tanoh Méa-Assande Gladys Oka-Berete Nathalie Zobo Patrick Acquah Marie-Berthe Kokora Tanoh François Eboua Marguerite Timité-Konan Lucrèce Diecket Ahoussou Julie Kebé Assouan Mabéa Flora Sami Clémence Kouadio Lorna Renner Bamenla Goka Jennifer Welbeck Adziri Sackey Seth Ntiri Owiafe Christian Wejse Zacarias José Da Silva Joao Paulo Amabelia Rodrigues David da Silva Candida Medina Ines Oliviera-Souto Lars Ostergaard Alex Laursen Morten Sodemann Peter Aaby Anders Fomsgaard Christian Erikstrup Jesper Eugen-Olsen Moussa Y Maïga Fatoumata Fofana Diakité Abdoulaye Kalle Drissa Katile Hamar Alassane Traore Daouda Minta Tidiani Cissé Mamadou Dembelé Mohammed Doumbia Mahamadou Fomba Assétou Soukho Kaya Abdoulaye M Traoré Hamady Traoré Amadou Abathina Toure Fatoumata Dicko Mariam Sylla Alima Berthé Hadizatou Coulibaly Traoré Anta Koïta Niaboula Koné Clémentine N'diaye Safiatou Touré Coulibaly Mamadou Traoré Naïchata Traoré Man Charurat Samuel Ajayi Stephen Dapiap Otu Festus Igbinoba Okwara Benson Clément Adebamowo Jesse James Obaseki Philip Osakede John Olasode Papa Salif Sow Bernard Diop Noël Magloire Manga Judicael Malick Tine Haby Signate Sy Abou Ba Aida Diagne Hélène Dior Malick Faye Ramatoulaye Diagne Gueye Aminata Diack Mbaye Akessiwe Patassi Awèrou Kotosso Benjamin Goilibe Kariyare Gafarou Gbadamassi Agbo Komi Kankoé Edem Mensah-Zukong Pinuwe Pakpame Annette Koko Lawson-Evi Yawo Atakouma Elom Takassi Améyo Djeha Ayoko Ephoévi-Gah Sherifa El-Hadj Djibril François Dabis Emmanuel Bissagnene Elise Arrivé Patrick Coffie Didier Ekouevi Antoine Jaquet Valériane Leroy Charlotte Lewden Annie Sasco Jean-Claude Azani Gérard Allou Eric Balestre Franck Bohossou Sophie Karcher Jules Mahan Gonsan Jérôme Le Carrou Séverin Lenaud Célestin Nchot Karen Malateste Amon Roseamonde Yao Bertine Siloué Gwenaelle Clouet Hugues Djetouan Alexandra Doring Adrienne Kouakou Elodie Rabourdin Jean Rivenc Xavier Anglaret Boubacar Ba Jean Bosco Essanin Andrea Ciaranello Sébastien Datté Sophie Desmonde Jean-Serge Elvis Diby Geoffrey S Gottlieb Apollinaire Gninlgninrin Horo Serge N'zoré Kangah Denis Malvy David Meless Aida Mounkaila-Harouna Camille Ndondoki Caroline Shiboski Rodolphe Thiébaut Pac-Ci Abidjan

PLoS One 2013 18;8(6):e66135. Epub 2013 Jun 18.

Université Bordeaux Segalen, ISPED, Centre INSERM U897- Epidémiologie-Biostatistique, Bordeaux, France ; Programme PACCI, Abidjan, Côte d'Ivoire ; Département des Sciences Fondamentales et Santé Publique, Université de Lomé, Lomé, Togo.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066135PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688850PMC
October 2017
104 Reads
10 Citations
3.234 Impact Factor

Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.

PLoS One 2015 25;10(6):e0129886. Epub 2015 Jun 25.

AP-HP, Hôpital Necker Enfants Malades, Laboratoire de Virologie, Paris, France; Université Paris-Descartes, Sorbonne Paris Cité, Faculté de Médecine, EA7327, Paris, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129886PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482391PMC
April 2016
31 Reads
5 Citations
3.234 Impact Factor

New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon.

Bull World Health Organ 2015 Aug 1;93(8):521-8. Epub 2015 Jun 1.

INSERM, Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F-75013, Paris, France .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2471/BLT.14.147892DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581657PMC
August 2015
42 Reads
3 Citations
5.090 Impact Factor

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

N Engl J Med 2015 Aug 20;373(9):808-22. Epub 2015 Jul 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1507198DOI Listing
August 2015
75 Reads
264 Citations
55.873 Impact Factor

Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration.

BMC Infect Dis 2015 Apr 9;15:176. Epub 2015 Apr 9.

Programme PAC-CI, Centre Hospitalier Universitaire (CHU) de Treichville, 18 BP 1954, Abidjan 18, Côte d'Ivoire.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-015-0910-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396560PMC
April 2015
18 Reads
1 Citation
2.613 Impact Factor

Re-testing and misclassification of HIV-2 and HIV-1&2 dually reactive patients among the HIV-2 cohort of the West African Database to evaluate AIDS collaboration.

J Int AIDS Soc 2014 11;17:19064. Epub 2014 Aug 11.

Centre INSERM U897-Epidémiologie-Biostatistique, ISPED, Université de Bordeaux, Bordeaux, France; Inserm U897, ISPED, Université de Bordeaux, Bordeaux, France; Programme PACCI, Site de recherche ANRS, Abidjan, Côte d'Ivoire; Département des Sciences Fondamentales et Santé Publique, Université de Lomé, Lomé-Togo.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134669PMC
http://dx.doi.org/10.7448/IAS.17.1.19064DOI Listing
March 2015
34 Reads
7 Citations
5.090 Impact Factor

Risk factors for cervical intraepithelial neoplasia in HIV-infected women on antiretroviral treatment in Côte d'Ivoire, West Africa.

PLoS One 2014 4;9(3):e90625. Epub 2014 Mar 4.

Université Bordeaux, ISPED, Centre INSERM U897-Epidémiologie-Biostatistique, Bordeaux, France; INSERM, ISPED, Centre INSERM U897- Epidémiologie-Biostatistique, Bordeaux, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0090625PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942459PMC
November 2014
28 Reads
6 Citations
3.234 Impact Factor

Incidence of pregnancy after antiretroviral therapy initiation and associated factors in 8 West African countries.

J Acquir Immune Defic Syndr 2014 Oct;67(2):e45-54

*Université de Bordeaux, ISPED, Centre INSERM U897-Epidémiologie-Biostatistique, Bordeaux, France; †INSERM, ISPED, Centre INSERM U897-Epidémiologie-Biostatistique, Bordeaux, France; ‡Centre Médical de Suivi de Donneurs de Sang (CMSDS), Abidjan, Côte d'Ivoire; §University of Abuja Teaching Hospital (UATH), Abuja, Nigeria; ‖Hôpital de jour, CHU Souro Sanou, Bobo Dioulasso, Burkina-Faso; ¶Centre de Prise en Charge des Personnes vivant avec le VIH, CHNU, Cotonou, Benin; and #Département des sciences fondamentales et santé publique, faculté des sciences de la santé, université de Lomé, Lomé, Togo.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/jaids/2014/10010/Incidence_of_P
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAI.0000000000000279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166575PMC
October 2014
42 Reads
2 Citations
4.560 Impact Factor

Genotypic resistance profiles of HIV-2-treated patients in West Africa.

AIDS 2014 May;28(8):1161-9

aLaboratoire de Virologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Bichat-Claude Bernard, HUPNVS, Université Paris Diderot, Sorbonne Paris Cité, Paris, France bDepartment of Infectious and Tropical Diseases, Treichville University Teaching Hospital cDepartment of Dermatology-Infectiology, Medical School, University Felix Houphouët-Boigny dProgramme PACCI, Site ANRS, Abidjan, Côte d'Ivoire eUniversité Bordeaux, INSERM, IPSED, Centre INSERM U897-Epidémiologie et Biostatistique fINSERM, IPSED, Centre INSERM U897-Epidémiologie et Biostatistique, Bordeaux gLaboratoire de Virologie, Faculté de Médecine, AP-HP, Hôpital Necker, Université René Descartes, Sorbonne Paris Cité, Paris hLaboratoire de Virologie, Pôle de Biologie Clinique, Hôpital Charles Nicolle, CHU de Rouen and EA2656, IRIB, Université de Rouen, Rouen iLaboratoire de Pharmaco-Toxicologie, AP-HP, Groupe Hospitalier Bichat-Claude Bernard, HUPNVS, Université Paris Diderot, Sorbonne Paris Cité, Paris, France jFaculté des Sciences de la Santé, Département de Santé Publique, Université de Lomé, Lomé, Togo.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000244DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112041PMC
May 2014
15 Reads
10 Citations
5.554 Impact Factor

Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.

J Acquir Immune Defic Syndr 2014 Jan;65(1):e8-16

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3182a39979DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894575PMC
January 2014
74 Reads
58 Citations
4.560 Impact Factor

Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008.

BMC Infect Dis 2013 Dec 27;13:607. Epub 2013 Dec 27.

Programme PAC-CI, Centre Hospitalier Universitaire (CHU) de Treichville, 18 BP 1954, Abidjan, Côte d'Ivoire.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2334-13-607DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880348PMC
December 2013
19 Reads
4 Citations
2.613 Impact Factor

Increasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in Côte d'Ivoire, West Africa.

J Acquir Immune Defic Syndr 2013 Oct;64(2):211-9

*Programme PAC-CI/ANRS, Abidjan, Côte d'Ivoire; †INSERM, Centre 897, France; ‡University of Bordeaux, ISPED, France; §Laboratoire de Virologie, Université Paris Descartes, Sorbonne Paris Cité, AP-HP, CHU Necker-Enfants Malades, Paris; ‖CeDReS, CHU de Treichville, Abidjan, Côte d'Ivoire; and ¶Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Côte d'Ivoire.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3182a009e4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834582PMC
October 2013
71 Reads
8 Citations
4.560 Impact Factor

Dried cervical spots for human papillomaviruses identification.

J Med Virol 2013 Jul 17;85(7):1222-8. Epub 2013 Apr 17.

University Hospital of Bordeaux, Virology Laboratory and Biology Department, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.23573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456434PMC
July 2013
8 Reads
2 Citations
2.350 Impact Factor

Development of a checklist of quality indicators for clinical trials in resource-limited countries: the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) experience.

Clin Trials 2013 Apr 23;10(2):300-18. Epub 2013 Jan 23.

INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux Segalen University, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774512470765DOI Listing
April 2013
12 Reads
2 Citations
1.925 Impact Factor

Impact of HIV type 1 DNA levels on spontaneous disease progression: a meta-analysis.

AIDS Res Hum Retroviruses 2012 Apr 30;28(4):366-73. Epub 2011 Aug 30.

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, University of Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/aid.2011.0032DOI Listing
April 2012
20 Reads
5 Citations
2.330 Impact Factor

Cervical cancer screening by visual inspection in Côte d'Ivoire, operational and clinical aspects according to HIV status.

BMC Public Health 2012 Mar 23;12:237. Epub 2012 Mar 23.

Service de Gynécologie Obstétrique, Centre Hospitalier Universitaire de Yopougon, Abidjan, Côte d'Ivoire, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2458-12-237DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328262PMC
March 2012
14 Reads
26 Citations
2.264 Impact Factor

Pharmacovigilance for antiretroviral drugs in Africa: lessons from a study in Abidjan, Cote d'Ivoire.

Pharmacoepidemiol Drug Saf 2011 Dec 7;20(12):1303-10. Epub 2011 Jul 7.

INSERM CRE U 897, Institute of Public Health and Development, Université Victor Segalen, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.2182DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227553PMC
December 2011
15 Reads
7 Citations
2.940 Impact Factor

Alcohol use and non-adherence to antiretroviral therapy in HIV-infected patients in West Africa.

Addiction 2010 Aug 7;105(8):1416-21. Epub 2010 Jun 7.

HIV Epidemiology, INSERM CRE U 897, Institut de Santé Publique, Epidémiologie et Développement, Université Victor Segalen, Bordeaux 2, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1360-0443.2010.02978.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458514PMC
August 2010
63 Reads
30 Citations
4.740 Impact Factor

Risk behaviors in volunteer blood donors who seroconverted for HIV, Abidjan, Côte d'Ivoire 1997 to 2005.

Transfusion 2010 Apr 20;50(4):888-93. Epub 2009 Nov 20.

Programme PAC-CI, Abidjan, Côte d'Ivoire, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2009.02499.xDOI Listing
April 2010
9 Reads
4 Citations
3.230 Impact Factor

HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Côte d'Ivoire: A 4-year survey, 2002-2006.

AIDS Res Hum Retroviruses 2007 Sep;23(9):1155-60

Programme PAC-CI/Primo-CI ANRS 1220, Abidjan, Côte d'Ivoire.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/aid.2007.0072DOI Listing
September 2007
17 Reads
8 Citations
2.330 Impact Factor

Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa?

J Acquir Immune Defic Syndr 2007 May;45(1):115-22

INSERM EMI 03 38, Institut de Santé Publique, Epidémiologie, et Développement (ISPED), Université Victor Segalen Bordeaux 2, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e318050d277DOI Listing
May 2007
30 Reads
26 Citations
4.560 Impact Factor

Behavior assessment of blood donors facing the risk of HIV infection, Abidjan, Cotê D'Ivoire, 2001-2002.

J Acquir Immune Defic Syndr 2005 Apr;38(5):618-21

Programme PAC-CI, Abidjan, Côte d'Ivoire, France.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/jaids/2005/04150/Behavior_Asses
Web Search
April 2005
42 Reads
1 Citation
4.560 Impact Factor

Clinical and biological evolution of HIV-1 seroconverters in Abidjan, Côte d'Ivoire, 1997-2000.

J Acquir Immune Defic Syndr 2002 Feb;29(2):149-57

Unité INSERM 330, ISPED, Université Victor Segalen Bordeaux 2, Bordeaux, France.

View Article

Download full-text PDF

Source
February 2002
19 Reads
6 Citations
4.560 Impact Factor